Tuesday, 3 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q2 FY27

Shree Pushkar Chemicals & Fertilisers Q2 FY27 Results: Net Profit ₹35.7 Cr, Up 96.2% YoY

Shree Pushkar Chemicals & Fertilisers Ltd reported revenue from operations of ₹403.5 Cr (+58.2% YoY) and net profit of ₹35.7 Cr (+96.2% YoY) for Q2 FY27.

Q2 FY27 at a glance · ₹ crore
MetricQ2 FY27Q1 FY27Q2 FY26
Revenue from operations403.5280.1255.1
Other income3.24.93.3
Total income406.7284.9258.4
Profit before exceptional items & tax43.027.821.9
Profit before tax43.027.821.9
Net profit35.722.918.2
Operating margin10.6%9.8%8.5%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year+96.20%
Net profit, quarter on quarter+55.90%
Revenue, year on year+58.20%
Operating profit, year on year+114.00%
Operating profit, quarter on quarter+73.80%
Source

NSE results filing, NSE: SHREEPUSHK. Figures extracted from the filing.

Read the filing ↗

Shree Pushkar Chemicals & Fertilisers Ltd: key numbers

Share price
₹569.95
Market cap
₹1,843 Cr
Revenue (annual)
₹976.6 Cr
Net profit (annual)
₹70.10 Cr
P/E (TTM)
20.6×Sector 33.6×
Promoter holding
69.45%+0.09% QoQ
FII holding
0.58%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shree Pushkar Chemicals & Fertilisers Ltd

All →
22:32 IST BSE
Fund Raise

Shree Pushkar Chemicals & Fertilisers Fund Raise of ₹45 Cr

Shree Pushkar's board approved a preferential issue of 854,060 convertible warrants to Punit Makharia. The issue would raise about Rs.45.00 Crore at Rs.527 per warrant.

Value
₹45.00 Cr
16:59 IST BSE
Board Meeting Date

Shree Pushkar Chemicals & Fertilisers Board Meeting Date

Shree Pushkar Chemicals schedules a 2 November 2026 board meeting for September quarter results. Agenda also includes fund raising via preferential issue and authorised capital increase.